Cytokinetics | CYTK - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Amgen USD 3.83B 130M 2026-03
Arca Biopharma USD -34.43M 326K 2025-12
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD 514.3M 128.8M 2026-03
Brainstorm Cell Therapeutics USD -2.24M 197K 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cytokinetics USD -181.23M 2.86M 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Exelixis USD 251.34M 15.43M 2026-03
Geron USD -236K 10.55M 2026-03
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Ligand Pharmaceuticals USD 60.33M 40.29M 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.99B 340M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03